Latest Posts
About This Stock
More About This Stock
Read
Ignyta Announces Pricing Of Public Offering Of Common Stock

Article By:
Business Wire
Friday, October 20, 2017 2:00 AM EDT
Ignyta anticipates using the net proceeds from the offering to fund R&D activities for its development programs, including the clinical development and pre-commercialization activities of entrectinib, and ongoing development of other pipeline assets.
In this article: RXDX